Company

Outpace

Rocket Ship Rating

Rocket Ship Rating: 98 out of 100

We're revolutionizing cell therapy with protein design.

Also known as Outpace Bio, Outpace Bio, Inc.

Biotech & therapeutics
AI native

Status: Operatingas of 2026-09-17
Business model: B2B
Headquarters: Seattle, WA, United States
Founded: 2021
Customers: leading biopharma and academics
Legal name: Outpace Bio, Inc.

Open relationship map

Claim, correct or request removal

Record updated 28 September 2026

About

Outpace Bio pioneered the design of new biological function. Now we’re building a future where all cell therapies are effective, safe, and scalable.

Funding snapshot

Total raised: $144MSum of rounds, as of 2026-09-17Source (opens in a new tab)
Latest round: Series B, $144M2024-08-01

Funding rounds

Series B: $144M2024-08-01, Company stated
Round, 2024: $56M2024-07-17, SEC form D sold, 25 investors

Products

Other: OPB-101
Web: OPB-101
Web: OUTDRIVE™
Web: OUTLAST™
Web: OUTMATCH™
Web: OUTSAFE™
Web: OUTSMART™
Web: OUTSPACER™